搜尋結果
A Season Of Health Breaches, A Season Of Changes
Forbes· 5 日前As spring ushers in a season of transformation, the healthcare sector finds itself at a ...
Biden Administration Moving Marijuana To Less Severe Drug Class—Boosting Medical Uses, Reports Say
Forbes· 5 日前The federal government considers Schedule I drugs to be substances with no accepted medical use ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 4 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 1 日前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...
CVS posts big earnings miss, cuts profit outlook on higher medical costs
CNBC· 3 日前CVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 4 日前The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged ...
CVS Health Profits Tumble To $1.1 Billion On Higher Costs To Treat Seniors
Forbes· 4 日前CVS Health reported first quarter profits were cut almost in half to $1.1 billion compared to ...
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters· 5 日前, opens new tab to a law requiring them to negotiate the prices of their blockbuster blood clot ...
Higher Medical Costs Likely Weighed On CVS Health’s Q1 Earnings
Forbes· 6 日前Earnings will likely come in at about $1.74 on a per-share and adjusted basis, slightly above ...
Wag! Rebrands Dog Food Advisor, User-Friendly Redesign Drives Increased Engagement; Launches ...
Bastillepost· 5 日前Group Co., Nasdaq: PET) today reveals the highly anticipated rebrand of Dog Food Advisor (DFA) ...